spacer
spacer

PDBsum entry 3lau

Go to PDB code: 
protein ligands links
Transferase PDB id
3lau

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
251 a.a. *
Ligands
OFI
Waters ×92
* Residue conservation analysis
PDB id:
3lau
Name: Transferase
Title: Crystal structure of aurora2 kinase in complex with a gsk3beta inhibitor
Structure: Serine/threonine-protein kinase 6. Chain: a. Fragment: unp residues 125-399. Synonym: aurora kinase a, aurora-a, serine/threonine kinase 15, aurora/ipl1-related kinase 1, aurora-related kinase 1, hark1, breast tumor-amplified kinase. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: aik, ark1, aura, aurka, btak, stk15, stk6. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
2.10Å     R-factor:   0.203     R-free:   0.248
Authors: S.Maignan,J.P.Guilloteau,S.Pouzieux
Key ref: D.Lesuisse et al. (2010). Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2. Bioorg Med Chem Lett, 20, 1985-1989. PubMed id: 20167481
Date:
07-Jan-10     Release date:   02-Mar-10    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O14965  (AURKA_HUMAN) -  Aurora kinase A from Homo sapiens
Seq:
Struc:
403 a.a.
251 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.2.7.11.1  - non-specific serine/threonine protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Bioorg Med Chem Lett 20:1985-1989 (2010)
PubMed id: 20167481  
 
 
Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.
D.Lesuisse, G.Dutruc-Rosset, G.Tiraboschi, M.K.Dreyer, S.Maignan, A.Chevalier, F.Halley, P.Bertrand, M.C.Burgevin, D.Quarteronet, T.Rooney.
 
  ABSTRACT  
 
From an HTS hit, a series of potent and selective inhibitors of GSK3beta have been designed based on a Cdk2-homology model and with the help of several crystal structures of the compounds within Cdk2.
 

 

spacer

spacer